Citius Oncology, Inc. - Common Stock

Citius Oncology, Inc. - Common Stock Share · US17331Y1091 · CTOR (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Citius Oncology, Inc. - Common Stock
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
2
0
0
0
No Price
01.05.2026 21:48
Current Prices from Citius Oncology, Inc. - Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
CTOR
USD
01.05.2026 21:48
0,95 USD
0,07 USD
+7,97 %
IEXG: IEX
IEX
CTOR
USD
01.05.2026 19:44
0,94 USD
0,06 USD
+6,52 %
Share Float & Liquidity
Free Float 5,39 %
Shares Float 4,75 M
Shares Outstanding 88,28 M
Company Profile for Citius Oncology, Inc. - Common Stock Share
Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York. Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.

Company Data

Name Citius Oncology, Inc. - Common Stock
Company Citius Oncology, Inc.
Symbol CTOR
Website https://www.citiusonc.com/overview/default.aspx
Primary Exchange XNAS NASDAQ
ISIN US17331Y1091
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Leonard L. Mazur
Market Capitalization 83 Mio
Country United States of America
Currency USD
Employees -
Address 420 Lexington Avenue, 10170 New York City

ID Changes

Date From To
13.08.2024 TENK CTOR

Ticker Symbols

Name Symbol
NASDAQ CTOR
More Shares
Investors who hold Citius Oncology, Inc. - Common Stock also have the following shares in their portfolio:
AMUNDI INVESTMENT FUNDS - TACTICAL ALLOCATION FUND - M EUR (C)
AMUNDI INVESTMENT FUNDS - TACTICAL ALLOCATION FUND - M EUR (C) ETF
Norddeutsche Landesbank -GZ- EO-IHS 23(38)
Norddeutsche Landesbank -GZ- EO-IHS 23(38) Unknown